{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:11:36Z","timestamp":1778227896368,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:00:00Z","timestamp":1708214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:00:00Z","timestamp":1708214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB216004"],"award-info":[{"award-number":["20232BAB216004"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Obesity is the most important driver of non-alcoholic fatty liver disease (NAFLD); nevertheless, the relationship of weight-adjusted waist index (WWI), a new obesity index, with NAFLD is unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study used data from the NAGALA project from 1994 to 2016. WWI values were calculated using waist circumference (WC) and weight measurements of the participants. Three stepwise adjusted logistic regression models were developed to assess the relationship of WWI with NAFLD in the whole population and in both sexes. Additionally, we also conducted a series of exploratory analysis to test the potential impact of body mass index (BMI), age, smoking status and exercise habits on the association of WWI with NAFLD. Receiver operating characteristic (ROC) curves were used to estimate cut-off points for identifying NAFLD in the entire population and in both sexes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The current study included a population of 11,805 individuals who participated in health screenings, including 6,451 men and 5,354 women. After adjusting for all non-collinear variables in the multivariable logistic regression model, we found a significant positive correlation of WWI with NAFLD. For each unit increase in WWI, the risk of NAFLD increased by 72% in the entire population, by 84% in men, and by 63% in women. Furthermore, subgroup analyses revealed no significant discrepancies in the correlation of WWI with NAFLD across individuals with varying ages, exercise habits, and smoking status (all <jats:italic>P<\/jats:italic>-interaction\u2009&gt;\u20090.05), except for different BMI groups (<jats:italic>P<\/jats:italic>-interaction\u2009&lt;\u20090.05). Specifically, compared to the overweight\/obese group, the relationship of WWI with NAFLD was significantly stronger in the non-obese group, especially in non-obese men. Finally, based on the results of ROC analysis, we determined that the WWI cut-off point used to identify NAFLD was 9.7675 in men and 9.9987 in women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study is the first to establish a positive correlation between WWI and NAFLD. Moreover, assessing the influence of WWI on NAFLD in individuals without obesity may yield more valuable insights compared to those who are overweight or obese.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-024-01554-z","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T10:01:41Z","timestamp":1708250501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study"],"prefix":"10.1186","volume":"24","author":[{"given":"Changhui","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiming","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maobin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guotai","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,18]]},"reference":[{"key":"1554_CR1","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology. 2020;158:1851\u201364. https:\/\/doi.org\/10.1053\/j.gastro.2020.01.052.","journal-title":"Gastroenterology"},{"key":"1554_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335\u201347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004.","journal-title":"Hepatology"},{"key":"1554_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1554_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","volume":"28","author":"A Kotronen","year":"2008","unstructured":"Kotronen A, Yki-J\u00e4rvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:27\u201338. https:\/\/doi.org\/10.1161\/ATVBAHA.107.147538.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1554_CR5","doi-asserted-by":"publisher","first-page":"3920196","DOI":"10.1155\/2020\/3920196","volume":"2020","author":"DM Tanase","year":"2020","unstructured":"Tanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM, Maranduca MA, et al. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD). J Diabetes Res. 2020;2020:3920196. https:\/\/doi.org\/10.1155\/2020\/3920196.","journal-title":"J Diabetes Res"},{"key":"1554_CR6","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut. 2020;69:1691\u2013705. https:\/\/doi.org\/10.1136\/gutjnl-2020-320622.","journal-title":"Gut"},{"key":"1554_CR7","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.3390\/ijms232113320","volume":"23","author":"A Lonardo","year":"2022","unstructured":"Lonardo A, Mantovani A, Targher G, Baffy G. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications. Int J Mol Sci. 2022;23:13320. https:\/\/doi.org\/10.3390\/ijms232113320.","journal-title":"Int J Mol Sci"},{"key":"1554_CR8","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.cgh.2020.05.009","volume":"19","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhao X, Chen S, Wang Y, Cao L, Liao W, et al. Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China. Clin Gastroenterol Hepatol. 2021;19:788\u2013796.e4. https:\/\/doi.org\/10.1016\/j.cgh.2020.05.009.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1554_CR9","doi-asserted-by":"publisher","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","volume":"23","author":"BJ Perumpail","year":"2017","unstructured":"Perumpail BJ, Khan MA, Yoo ER, Cholankeril G, Kim D, Ahmed A. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol. 2017;23:8263\u201376. https:\/\/doi.org\/10.3748\/wjg.v23.i47.8263.","journal-title":"World J Gastroenterol"},{"key":"1554_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.014.","journal-title":"Metabolism"},{"key":"1554_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8:20\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(22)00317-X.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1554_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cld.2017.08.010","volume":"22","author":"D Kim","year":"2018","unstructured":"Kim D, Touros A, Kim WR. Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. Clin Liver Dis. 2018;22:133\u201340. https:\/\/doi.org\/10.1016\/j.cld.2017.08.010.","journal-title":"Clin Liver Dis"},{"key":"1554_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/obr.12407","volume":"17","author":"L Li","year":"2016","unstructured":"Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17:510\u20139. https:\/\/doi.org\/10.1111\/obr.12407.","journal-title":"Obes Rev"},{"key":"1554_CR14","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3748\/wjg.v21.i5.1650","volume":"21","author":"Q Pang","year":"2015","unstructured":"Pang Q, Zhang JY, Song SD, Qu K, Xu XS, Liu SS, et al. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World J Gastroenterol. 2015;21:1650\u201362. https:\/\/doi.org\/10.3748\/wjg.v21.i5.1650.","journal-title":"World J Gastroenterol"},{"key":"1554_CR15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ijo.2008.11","volume":"32","author":"A Romero-Corral","year":"2008","unstructured":"Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008;32:959\u201366. https:\/\/doi.org\/10.1038\/ijo.2008.11.","journal-title":"Int J Obes (Lond)"},{"key":"1554_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pcad.2018.05.005","volume":"61","author":"TB Horwich","year":"2018","unstructured":"Horwich TB, Fonarow GC, Clark AL. Obesity and the Obesity Paradox in Heart Failure. Prog Cardiovasc Dis. 2018;61:151\u20136. https:\/\/doi.org\/10.1016\/j.pcad.2018.05.005.","journal-title":"Prog Cardiovasc Dis"},{"key":"1554_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s40519-020-01015-1","volume":"26","author":"G Gravina","year":"2021","unstructured":"Gravina G, Ferrari F, Nebbiai G. The obesity paradox and diabetes. Eat Weight Disord. 2021;26:1057\u201368. https:\/\/doi.org\/10.1007\/s40519-020-01015-1.","journal-title":"Eat Weight Disord"},{"issue":"3","key":"1554_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40519-018-0505-2","volume":"23","author":"A Fassio","year":"2018","unstructured":"Fassio A, Idolazzi L, Rossini M, Gatti D, Adami G, Giollo A, et al. The obesity paradox and osteoporosis. Eat Weight Disord. 2018;23(3):293\u2013302. https:\/\/doi.org\/10.1007\/s40519-018-0505-2.","journal-title":"Eat Weight Disord"},{"key":"1554_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.14218\/JCTH.2019.00029","volume":"7","author":"IB Curcic","year":"2019","unstructured":"Curcic IB, Berkovic MC, Kuna L, Roguljic H, Smolic R, Varzic SC, et al. Obesity Paradox in Chronic Liver Diseases: Product of Bias or a Real Thing? J Clin Transl Hepatol. 2019;7:275\u20139. https:\/\/doi.org\/10.14218\/JCTH.2019.00029.","journal-title":"J Clin Transl Hepatol"},{"key":"1554_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.puhe.2021.07.042","volume":"198","author":"I Mahmoud","year":"2021","unstructured":"Mahmoud I, Al-Wandi AS, Gharaibeh SS, Mohamed SA. Concordances and correlations between anthropometric indices of obesity: a systematic review. Public Health. 2021;198:301\u20136. https:\/\/doi.org\/10.1016\/j.puhe.2021.07.042.","journal-title":"Public Health"},{"key":"1554_CR21","doi-asserted-by":"publisher","first-page":"16753","DOI":"10.1038\/s41598-018-35073-4","volume":"8","author":"Y Park","year":"2018","unstructured":"Park Y, Kim NH, Kwon TY, Kim SG. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Sci Rep. 2018;8:16753. https:\/\/doi.org\/10.1038\/s41598-018-35073-4.","journal-title":"Sci Rep"},{"key":"1554_CR22","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/ageing\/afaa208","volume":"50","author":"NH Kim","year":"2021","unstructured":"Kim NH, Park Y, Kim NH, Kim SG. Weight-adjusted waist index reflects fat and muscle mass in the opposite direction in older adults. Age Ageing. 2021;50:780\u20136. https:\/\/doi.org\/10.1093\/ageing\/afaa208.","journal-title":"Age Ageing"},{"key":"1554_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.4093\/dmj.2021.0294","volume":"46","author":"JY Kim","year":"2022","unstructured":"Kim JY, Choi J, Vella CA, Criqui MH, Allison MA, Kim NH. Associations between Weight-Adjusted Waist Index and Abdominal Fat and Muscle Mass: Multi-Ethnic Study of Atherosclerosis. Diabetes Metab J. 2022;46:747\u201355. https:\/\/doi.org\/10.4093\/dmj.2021.0294.","journal-title":"Diabetes Metab J"},{"issue":"5","key":"1554_CR24","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.numecd.2022.01.033","volume":"32","author":"C Ding","year":"2022","unstructured":"Ding C, Shi Y, Li J, Li M, Hu L, Rao J, et al. Association of weight-adjusted-waist index with all-cause and cardiovascular mortality in China: A prospective cohort study. Nutr Metab Cardiovasc Dis. 2022;32(5):1210\u20137. https:\/\/doi.org\/10.1016\/j.numecd.2022.01.033.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1554_CR25","doi-asserted-by":"publisher","first-page":"1069146","DOI":"10.3389\/fcvm.2022.1069146","volume":"9","author":"D Zhang","year":"2022","unstructured":"Zhang D, Shi W, Ding Z, Park J, Wu S, Zhang J. Association between weight-adjusted-waist index and heart failure: Results from National Health and Nutrition Examination Survey 1999\u20132018. Front Cardiovasc Med. 2022;9:1069146. https:\/\/doi.org\/10.3389\/fcvm.2022.1069146.","journal-title":"Front Cardiovasc Med"},{"key":"1554_CR26","doi-asserted-by":"publisher","first-page":"1007557","DOI":"10.3389\/fendo.2022.1007557","volume":"13","author":"P Zhao","year":"2022","unstructured":"Zhao P, Shi W, Shi Y, Xiong Y, Ding C, Song X, et al. Positive association between weight-adjusted-waist index and hyperuricemia in patients with hypertension: The China H-type hypertension registry study. Front Endocrinol (Lausanne). 2022;13:1007557. https:\/\/doi.org\/10.3389\/fendo.2022.1007557.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1554_CR27","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3390\/jcm12041620","volume":"12","author":"S Yu","year":"2023","unstructured":"Yu S, Wang B, Guo X, Li G, Yang H, Sun Y. Weight-Adjusted-Waist Index Predicts Newly Diagnosed Diabetes in Chinese Rural Adults. J Clin Med. 2023;12:1620. https:\/\/doi.org\/10.3390\/jcm12041620.","journal-title":"J Clin Med"},{"key":"1554_CR28","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.numecd.2020.05.033","volume":"30","author":"Q Li","year":"2020","unstructured":"Li Q, Qie R, Qin P, Zhang D, Guo C, Zhou Q, et al. Association of weight-adjusted-waist index with incident hypertension: The Rural Chinese Cohort Study. Nutr Metab Cardiovasc Dis. 2020;30:1732\u201341. https:\/\/doi.org\/10.1016\/j.numecd.2020.05.033.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1554_CR29","doi-asserted-by":"publisher","first-page":"941926","DOI":"10.3389\/fnut.2022.941926","volume":"9","author":"Z Qin","year":"2022","unstructured":"Qin Z, Chang K, Yang Q, Yu Q, Liao R, Su B. The association between weight-adjusted-waist index and increased urinary albumin excretion in adults: A population-based study. Front Nutr. 2022;9:941926. https:\/\/doi.org\/10.3389\/fnut.2022.941926.","journal-title":"Front Nutr"},{"key":"1554_CR30","doi-asserted-by":"publisher","first-page":"1159055","DOI":"10.3389\/fendo.2023.1159055","volume":"14","author":"Y Shen","year":"2023","unstructured":"Shen Y, Wu Y, Fu M, Zhu K, Wang J. Association between weight-adjusted-waist index with hepatic steatosis and liver fibrosis: a nationally representative cross-sectional study from NHANES 2017 to 2020. Front Endocrinol (Lausanne). 2023;14:1159055. https:\/\/doi.org\/10.3389\/fendo.2023.1159055.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1554_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41366-018-0076-3","volume":"43","author":"T Okamura","year":"2019","unstructured":"Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes (Lond). 2019;43:139\u201348. https:\/\/doi.org\/10.1038\/s41366-018-0076-3.","journal-title":"Int J Obes (Lond)"},{"key":"1554_CR32","doi-asserted-by":"publisher","unstructured":"Okamura T, et al. Data from: Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Dryad, Dataset. 2019. https:\/\/doi.org\/10.5061\/dryad.8q0p192.","DOI":"10.5061\/dryad.8q0p192"},{"key":"1554_CR33","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","volume":"102","author":"M Hamaguchi","year":"2007","unstructured":"Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102:2708\u201315. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01526.x.","journal-title":"Am J Gastroenterol"},{"key":"1554_CR34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4097\/kja.19087","volume":"72","author":"JH Kim","year":"2019","unstructured":"Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019;72:558\u201369. https:\/\/doi.org\/10.4097\/kja.19087.","journal-title":"Korean J Anesthesiol"},{"issue":"6","key":"1554_CR35","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","volume":"34","author":"S Ballestri","year":"2017","unstructured":"Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. Adv Ther. 2017;34(6):1291\u2013326. https:\/\/doi.org\/10.1007\/s12325-017-0556-1.","journal-title":"Adv Ther"},{"key":"1554_CR36","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/ijms21113863","volume":"21","author":"H Fujii","year":"2020","unstructured":"Fujii H, Kawada N, Japan Study Group Of NafldJsg-Nafld. The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease. Int J Mol Sci. 2020;21:3863. https:\/\/doi.org\/10.3390\/ijms21113863.","journal-title":"Int J Mol Sci."},{"key":"1554_CR37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1152\/physrev.00033.2011","volume":"93","author":"A Tchernof","year":"2013","unstructured":"Tchernof A, Despr\u00e9s JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93:359\u2013404. https:\/\/doi.org\/10.1152\/physrev.00033.2011.","journal-title":"Physiol Rev"},{"issue":"6","key":"1554_CR38","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s12072-019-09996-7","volume":"13","author":"JA Kim","year":"2019","unstructured":"Kim JA, Choi KM. Sarcopenia and fatty liver disease. Hepatol Int. 2019;13(6):674\u201387. https:\/\/doi.org\/10.1007\/s12072-019-09996-7.","journal-title":"Hepatol Int"},{"key":"1554_CR39","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/obr.12776","volume":"20","author":"CH De Fr\u00e9","year":"2019","unstructured":"De Fr\u00e9 CH, De Fr\u00e9 MA, Kwanten WJ, Op de Beeck BJ, Beeck BJ, Van Gaal LF, Francque SM. Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity? Obes Rev. 2019;20:353\u201363. https:\/\/doi.org\/10.1111\/obr.12776.","journal-title":"Obes Rev."},{"key":"1554_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00535-016-1264-3","volume":"52","author":"WK Seto","year":"2017","unstructured":"Seto WK, Yuen MF. Nonalcoholic fatty liver disease in Asia: emerging perspectives. J Gastroenterol. 2017;52:164\u201374. https:\/\/doi.org\/10.1007\/s00535-016-1264-3.","journal-title":"J Gastroenterol"},{"issue":"8","key":"1554_CR41","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(8):739\u201352. https:\/\/doi.org\/10.1016\/S2468-1253(20)30077-7.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1554_CR42","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.3350\/cmh.2022.0350","volume":"29","author":"WK Chan","year":"2023","unstructured":"Chan WK. Comparison between obese and non-obese nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29:S58\u201367. https:\/\/doi.org\/10.3350\/cmh.2022.0350.","journal-title":"Clin Mol Hepatol"},{"key":"1554_CR43","doi-asserted-by":"publisher","first-page":"502","DOI":"10.14218\/JCTH.2022.00204","volume":"11","author":"AH Patel","year":"2023","unstructured":"Patel AH, Peddu D, Amin S, Elsaid MI, Minacapelli CD, Chandler TM, et al. Nonalcoholic Fatty Liver Disease in Lean\/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment. J Clin Transl Hepatol. 2023;11:502\u201315. https:\/\/doi.org\/10.14218\/JCTH.2022.00204.","journal-title":"J Clin Transl Hepatol"},{"key":"1554_CR44","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","volume":"15","author":"D Kim","year":"2017","unstructured":"Kim D, Kim WR. Nonobese Fatty Liver Disease. Clin Gastroenterol Hepatol. 2017;15:474\u201385. https:\/\/doi.org\/10.1016\/j.cgh.2016.08.028.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1554_CR45","doi-asserted-by":"publisher","first-page":"113331","DOI":"10.1016\/j.biopha.2022.113331","volume":"153","author":"R Xu","year":"2022","unstructured":"Xu R, Pan J, Zhou W, Ji G, Dang Y. Recent advances in lean NAFLD. Biomed Pharmacother. 2022;153:113331. https:\/\/doi.org\/10.1016\/j.biopha.2022.113331.","journal-title":"Biomed Pharmacother"},{"key":"1554_CR46","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328\u201357. https:\/\/doi.org\/10.1002\/hep.29367.","journal-title":"Hepatology"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01554-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-024-01554-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01554-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T10:01:45Z","timestamp":1708250505000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-024-01554-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1554"],"URL":"https:\/\/doi.org\/10.1186\/s12902-024-01554-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,18]]},"assertion":[{"value":"22 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NAGALA project was authorized by the Murakami Memorial Hospital Ethics Committee, and informed consent for data usage was obtained from each participant. The current study is a post-hoc analysis based on the data from the NAGALA project, and the research protocol and design were authorized by Jiangxi Provincial People's Hospital Ethics Committee (IRB 2021\u2013066). We confirm that all methods were carried out in accordance with relevant guidelines and regulation under the \u2018Ethics approval and consent to participate\u2019 in the declaration section of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}